Search

Your search keyword '"Kaltenbach, Lisa A."' showing total 53 results

Search Constraints

Start Over You searched for: Author "Kaltenbach, Lisa A." Remove constraint Author: "Kaltenbach, Lisa A." Database Academic Search Index Remove constraint Database: Academic Search Index
53 results on '"Kaltenbach, Lisa A."'

Search Results

1. Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.

3. Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.

4. Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization.

5. CHARACTERIZING THE DIGITAL DIVIDE & ACCESS TO MOBILE HEALTH INTERVENTIONS IN HEART FAILURE: INSIGHTS FROM THE CONNECT-HF MHEALTH SUBSTUDY.

6. ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL.

7. Investigation of kinetic interactions between approved oximes and human acetylcholinesterase inhibited by pesticide carbamates.

8. The Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Analysis From the National Cardiovascular Data Registry (2007 to 2011)

9. Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.

10. The impact of beta-blocker therapy on anemia after traumatic brain injury.

11. Prevalence and Outcomes of Same-Day Discharge After Elective Percutaneous Coronary Intervention Among Older Patients.

12. Initiation of rheumatoid arthritis treatments and the risk of serious infections.

13. SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE.

15. PERSISTENCE AND DISCONTINUATION OF SGLT-2I AND GLP-1RA AMONG PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE TREATED IN US CARDIOLOGY CLINICS: INSIGHTS FROM THE COORDINATE-DIABETES TRIAL.

16. CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL.

22. PATTERNS OF ANGINA AND ANTIANGINAL MEDICATION USE AMONG PATIENTS FOLLOWING MI TREATED WITH PCI: INSIGHTS FROM TRANSLATE-ACS.

24. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.

27. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)

28. Adoption of Radial Access and Comparison of Outcomes to Femoral Access in Percutaneous Coronary Intervention An Updated Report from the National Cardiovascular Data Registry (2007–2012).

29. Nonsystem Reasons for Delay in Door-to-Balloon Time and Associated In-Hospital Mortality: A Report From the National Cardiovascular Data Registry

30. Patterns and Predictors of Evidence-Based Medication Continuation Among Hospitalized Heart Failure Patients (from Get With the Guidelines–Heart Failure)

31. Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial.

32. Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.

33. INTERVENTION TO IMPROVE GUIDELINE-BASED CARE FOR DIABETES AND CARDIOVASCULAR DISEASE IS EFFECTIVE IN BLACK AND HISPANIC POPULATIONS.

34. Abstract 14759: The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial.

35. Abstract 14117: Method of Assessing Medication Persistence and Clinical Outcomes: A Comparison of Patient Report and Pharmacy Fill Data From the ARTEMIS Trial.

36. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.

38. Outcomes of a multi-community hypertension implementation study: the American Heart Association's Check. Change. Control. program.

41. Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age.

42. Hospital Variability in the Rate of Finding Obstructive Coronary Artery Disease at Elective, Diagnostic Coronary Angiography

43. Patient centered primary care is associated with patient hypertension medication adherence.

44. Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention.

45. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

46. Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors.

47. Selected Community Characteristics and Underage Drinking.

48. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.

49. Abstract 14416: Strategies for Improving the Care of Patients Hospitalized With Heart Failure: Baseline Data From the CONNECT-HF Trial.

Catalog

Books, media, physical & digital resources